Express Scripts 2011 Annual Report Download - page 5

Download and view the complete annual report

Please find page 5 of the 2011 Express Scripts annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 108

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108

healthcare overall. This merger is
a perfect example of our growth
model.
The transaction, which closed
on April 2, 2012, is what the
nation needed. Massive changes
are on the horizon for our
industry, including healthcare
reform and the upcoming wave of
brand-name drugs losing patent
protection. Meanwhile, healthcare
costs continue to rise. In this
environment, we have to be nimble.
We have to be smart enough to
influence events and forward
thinking enough to interpret
events before they occur.
Express Scripts cannot allow the
cost of prescription medications
to overburden American families.
Tough economic times should not
translate to tradeoffs with one’s
healthcare. The merger accelerates
our ability to protect consumers
from the rising cost of drugs,
giving us the opportunity for even
greater success.
Our breadth and depth of services
across traditional PBM management,
specialty management and Medicare
Part D will be unparalleled in the
industry, and we will be fully able to
help clients and members navigate
the landscape in the wake of
healthcare reform.
Our successful growth has been
augmented by strategic acquisitions
that utilize, through integration, the
best talent and practices for the
3
benefit of our clients, patients and
stockholders. We have a strong track
record of completing acquisitions,
integrating seamlessly, and meeting
or exceeding market expectations.
The merger accelerates our
ability to protect consumers
from the rising cost of drugs,
giving us the opportunity for
even greater success.
We currently expect $1 billion
of synergies once integration is
completed and expect to deliver
more than $4 billion of annual free
cash flow, excluding integration
costs. Express Scripts will be well
positioned to promote greater
efficiencies in the healthcare system
and deliver increased value to our
clients and patients, to better protect
millions of Americans.
I’m more excited about Express
Scripts today than I’ve been in my
time with the company. We stand
at the beginning of a year full of
opportunities to improve patient
health, make medications more
affordable and create the best
member experience in healthcare.
Sincerely,
George Paz
Chairman and CEO
Management Team
Keith Ebling
Executive Vice President &
Chief Legal Counsel
Brian Griffin
Senior Vice President &
President, International & Subsidiaries
Jeff Hall
Executive Vice President &
Chief Financial Officer
Chris Houston
Senior Vice President,
Pharma & Retail Strategy
Ed Ignaczak
Executive Vice President,
Sales & Marketing
Pat McNamee
Executive Vice President &
Chief Operating Officer
Steve Miller, MD
Senior Vice President &
Chief Medical Officer
George Paz
Chairman & Chief Executive Officer
Glen Stettin, MD
Senior Vice President,
Clinical, Research & New Solutions
Sara Wade
Senior Vice President &
Chief Human Resources Officer
Tim Wentworth
Senior Vice President &
President, Sales and
Account Management
Gary Wimberly
Senior Vice President &
Chief Information Officer
Larry Zarin
Senior Vice President &
Chief Marketing Officer